Memphis, TN – According to filings with the U.S. Securities and Exchange Commission, Spesana is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Carla Balch played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Spesana

We translate science into actionable care. Spesana is developing a visualization-based clinical decision support tool to help medical profesionals understand the results of molecular diagnostics tests as well as the large amounts of data that comes with the test results.

To learn more about Spesana, visit http://spesana.com/

Contact:
Carla Balch, Chief Executive Officer
901-634-7677
https://www.linkedin.com/in/carla-balch-hates-cancer/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved